Quinagolide hydrochloride manufacturers
|
| | Quinagolide hydrochloride Basic information |
| Product Name: | Quinagolide hydrochloride | | Synonyms: | QUINAGOLIDE HYDROCHLORIDE;(3S,4aS,10aR)-3-(Diethylsulfamoylamino)-6-hydroxy-1-propyl-3,4,4a,5,10,10a-hexahydro-2H-benzo[g]quinoline hydrochloride;Quinagolide hydrochloride (CV205-502 hydrochloride);(+/-)-N,N-diethyl-N'-<(3α,4aα,10aβ)-1,2,3,4,4a,5,10,10a-octahydro-6-hydroxy-1-propyl-3-benzoquinolinyl>sulfamide hydrochloride;(3α,4aα,10aβ)-N,N-Diethyl-N'-
(1,2,3,4,4a,5,10,10a-octahydro-6-hydroxy-1-propylbenzo[g]quinolin-3-yl)sulfaMide Monohydrochloride;Norprolac Hydrochloride;rel-N,N-Diethyl-N'-[(3R,4aR,10aS)-1,2,3,4,4a,5,10,10a-octahydro-6-hydroxy-1-propylbenzo[g]quinolin-3-yl]sulfaMide Hydrochloride;SDZ 205-502 | | CAS: | 94424-50-7 | | MF: | C20H34ClN3O3S | | MW: | 432.02 | | EINECS: | | | Product Categories: | Amines;Aromatics;Intermediates & Fine Chemicals;Pharmaceuticals;Sulfur & Selenium Compounds | | Mol File: | 94424-50-7.mol |  |
| | Quinagolide hydrochloride Chemical Properties |
| Melting point | 234-236° | | storage temp. | Store at -20°C | | solubility | DMSO : ≥ 43 mg/mL (99.53 mM) | | form | Solid | | color | White to off-white | | CAS DataBase Reference | 94424-50-7(CAS DataBase Reference) |
| | Quinagolide hydrochloride Usage And Synthesis |
| Description | Quinagolide is a potent and specific non-ergot dopamine D2 agonist launched in the Netherlands for the treatment of hyperprolactinemia. Quinagolide is
effective in inhibiting prolactin secretion by human pituitary tumor and
hyperprolactinemia in vitro and in viva A daily dose of as low as 60 pg is able to
achieve a pronounced and prolonged suppressive effect on serum prolactin and
growth hormone secretion. It is also effective in providing relief from associated
effects such as infertility, galactorrhea, oligomenorrhea, amenorrhea, loss of IibMo
and impotence. Compared with the most widely used antiprolactin, bromocriptine,
quinagolide is more potent in vivo with a longer duration of action and fewer side
effects. A recent study showed that acute administration of quinagolide suppresses
growth hormone secretion in acromegalic patients and thus could serve as an
alternative therapy in acromegaly. | | Originator | Sandoz (Switzerland) | | Uses | Quinagolide is a nonergot dopamine D2-receptor agonist. Quinagolide acts as an prolactin inhibitor. | | Brand name | Norprolac | | in vivo | Quinagolide hydrochloride (0.03-0.6 mg/kg; s.c. once daily for 2 month) effectively inhibits tumor growth in vivo[1]. | Animal Model: | Female Wistar-Furth rats bearing SMtTW tumors[1] | | Dosage: | 0.03-0.6 mg/kg | | Administration: | Subcutaneous injection; 0.03-0.6 mg/kg once daily for 2 month | | Result: | Induced normalization of plasma PRL levels in all animals, reduced the tumor size compared with the control group at a dose of 0.3 mg/kg. Showed maximal inhibitory effects on PRL secretion and tumor growth at a dose of 0.3 mg/kg.
|
|
| | Quinagolide hydrochloride Preparation Products And Raw materials |
|